In the months of May and June 2022, the European Medicines Agency (EMA) recommended granting various forms of marketing authorisation […]
Read MoreThe Professional Society for Health Economics and Outcomes Research (ISPOR) is organising a webinar entitled “Health Preference Research in the […]
Read MoreInnovative techniques in the biomedical field (such as massive sequencing capacity, gene editing and tissue engineering) have resulted in the development of new unconventional drugs in […]
Read MoreBased on evidence from a single-arm clinical trial, the European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European […]
Read MoreEuropaBio invites you for its first webinar in the Advanced Therapies series of events, interviews, and publications titled “Taking health up […]
Read More